341 – 350 of 351
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Classification of breast cancer using genetic algorithms and tissue microarrays
Dolled-Filhart, Marisa ; Rydén, Lisa LU
; Cregger, Melissa
; Jirström, Karin
LU
; Harigopal, Malini
; Camp, Robert L
and Rimm, David L
(2006)
In Clinical Cancer Research
12(21).
p.6459-6468
- Contribution to journal › Article
-
Mark
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
Brennan, Donal J. ; Jirström, Karin LU
; Kronblad, Åsa
LU
; Millikan, Robert C.
; Landberg, Göran
LU
; Duffy, Michael J.
; Rydén, Lisa
LU
; Gallagher, William M.
and O'Brien, Sallyann L.
(2006)
In Clinical Cancer Research
12(21).
p.6421-6431
- Contribution to journal › Article
- 2005
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
Svensson Månsson, Sofie LU ; Jirström, Karin LU
; Rydén, Lisa
LU
; Roos, G
; Emdin, S
; Ostrowski, M
and Landberg, Göran
LU
(2005)
In Oncogene
24(27).
p.4370-4379
- Contribution to journal › Article
-
Mark
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén, Lisa LU
; Jirström, Karin
LU
; Bendahl, Pär-Ola
LU
; Fernö, Mårten
LU
; Nordenskjöld, Bo
; Stål, Olle
; Thorstenson, Sten
; Jönsson, Per-Ebbe
LU
and Landberg, Göran
LU
(2005)
In Journal of Clinical Oncology
23(21).
p.4695-4704
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
Rydén, Lisa ; Jönsson, Per-Ebbe ; Chebil, Gunilla ; Dufmats, Monika ; Fernö, Mårten LU ; Jirström, Karin LU
; Källström, Ann-Christin
; Landberg, Göran
; Stål, Olle
and Thorstenson, Sten
, et al.
(2005)
In European Journal of Cancer
41(2).
p.256-264
- Contribution to journal › Article
-
Mark
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
Jirström, Karin LU
; Stendahl, Maria
LU
; Rydén, Lisa
LU
; Kronblad, Åsa
LU
; Bendahl, Pär-Ola
LU
; Stål, Olle
and Landberg, Göran
LU
(2005)
In Cancer Research
65(17).
p.8009-8016
- Contribution to journal › Article
-
Mark
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
Landberg, Göran LU ; Nilsson, Kristina LU ; Jirström, Karin LU
; Rydén, Lisa
LU
; Kitching, Richard
; Burger, Angelika M
and Seth, Arun
(2005)
In Breast Cancer Research and Treatment
89(3).
p.313-316
- Contribution to journal › Article
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
Berglund, Pontus LU ; Stighall, Maria LU ; Jirström, Karin LU
; Borgquist, Signe
LU
; Sjölander, Anita
LU
; Hedenfalk, Ingrid
LU
and Landberg, Göran
LU
(2005)
In Cancer Research
65(21).
p.9727-9734
- Contribution to journal › Article
-
Mark
TISSUE MICROARRAY PERSPECTIVES ON CYCLIN D1 IN BREAST CANCER: Progression, prognosis and prediction
Jirström, Karin LU
(2005)
- Thesis › Doctoral thesis (compilation)
-
Mark
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
Jirström, Karin LU
; Rydén, Lisa
LU
; Anagnostaki, L
; Nordenskjold, B
; Stal, O
; Thorstenson, S
; Chebil, G
; Jonsson, P-E
; Fernö, Mårten
LU
and Landberg, Göran
LU
(2005)
In Journal of Clinical Pathology
58(11).
p.1135-1142
- Contribution to journal › Article